MedPath

To study the effect of â??Dashemani Kandughna Gelâ?? local application in the management of Dandruff ( itching over scalp, Flakes on scalp etc)

Not Applicable
Conditions
Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Registration Number
CTRI/2020/12/030010
Lead Sponsor
Dr Nilima Sanjay Dharkar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Volunteers willing to participate and giving informed consent will be included in study

2) Patients of Either sex, age group18-50, suffering from Darunak (Dandruff )

Exclusion Criteria

1) Volunteers not willing to participate and giving informed consent

2) Age less than 18yrs or more than 50 yrs

3) Seborrheric dermatitis, Psoriasis of scalp,Eczema of scalp

4) Immune compromised conditions and systemic infections

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality standards will be generated for newly innovated Dashemani Kandughna Gel. <br/ ><br>Dashemani Kandughna Gel may show antimicrobial activity as against specific bacterial and fungal strains <br/ ><br>Dashemani Kandughna Gel might show antidandruff action inpubertal to middle age volunteers of age 18 to 50 years. <br/ ><br> <br/ ><br>Timepoint: Quality standards will be generated for newly innovated Dashemani Kandughna Gel. <br/ ><br>Dashemani Kandughna Gel may show antimicrobial activity as against specific bacterial and fungal strains <br/ ><br>Dashemani Kandughna Gel might show antidandruff action inpubertal to middle age volunteers of age 18 to 50 yearswith topical application f0r 21 days at night time daily.Weekly assessment will be done at 0, 7, 14, 21 days. <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Any untoward effec ts of Kadughna Dashemani gel during the studyTimepoint: During the study period of 21 days
© Copyright 2025. All Rights Reserved by MedPath